CD8 CD28 regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.
Stefanie Huhn, Peter Reimer, Roland Fenk, Manfred Hensel, Axel Benner, Uwe M Martens, Rolf Mahlberg, Elias K Mai, Uta Bertsch, Christof Scheid, Katja C Weisel, Markus Munder, Dirk Hose, Marc S Raab, Igor W Blau, Mathias Hänel, Hans J Salwender, Anna Jauch, Niels Weinhold, Hartmut Goldschmidt, Ullrich Graeven, Katharina Kriegsmann, Carsten Müller-Tidow, Jan Dürig, Stephan Kremers, Andrea Seidel-Glätzer, Britta Besemer, Christoph Mann, Roland Schroers, Ivana von Metzler, Aneta Schieferdecker, Jörg Thomalla, Christian Kunz, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad, Michael Hundemer
Leukemia 2024;38(7):1621-1625